Virginia Retirement Systems Et Al Cara Therapeutics, Inc. Transaction History

Virginia Retirement Systems Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 16, 2023	SELL	$8.24 - $12.56 $230,720 - $351,680	-28,000 Reduced 72.92%	10,400 $97.3 Million
Q1 2022 Apr 21, 2022	SELL	$9.94 - $12.65 $164,010 - $208,725	-16,500 Reduced 30.05%	38,400 $467,000
Q3 2021 Oct 21, 2021	SELL	$11.55 - $16.06 $82,005 - $114,025	-7,100 Reduced 11.45%	54,900 $848,000
Q2 2021 Aug 13, 2021	BUY	$12.38 - $29.19 $285,978 - $674,289	23,100 Added 59.38%	62,000 $885,000
Q1 2021 Apr 30, 2021	BUY	$15.07 - $21.71 $173,305 - $249,665	11,500 Added 41.97%	38,900 $845,000

Q4 2020 Feb 16, 2021	BUY	$12.72 - $16.16 $348,528 - $442,784	27,400 New	27,400 $415,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.